Advancing excellence in laboratory medicine for better healthcare worldwide
Latest news
  • Diagnóstico in Vitro - Febrero 2020

    Wednesday, February 26, 2020

    Diagnóstico in Vitro - Febrero 2020
    Enjoy the contents of the new DIAGNÓSTICO IN VITRO February issue.
    El número comienza con la editorial de la Dra. Maria del Carmen Pasquel, directora del DiV y sus saludos y felicitaciones al nuevo Chair del Grupo de Trabajo de Iberoamerica de Nomenclatura y Traducción (WG-IANT), dr. Raúl Girardi - Argentina, para el periodo enero 2020 hasta diciembre 2022. Lee todas las novedades y noticias, los artículos científicos, la carta al director, la sección dedicada a los jóvenes científicos IFCC y no olvides la entrevista "El Microscopio".
    In this issue the IFCC WG-IANT confirms its commitment to advance excellence in laboratory medicine for better healthcare worldwide in Latin America.
    Read more

  • Candidates for IFCC EB Regional Representative and Corporate Member position

    Tuesday, February 11, 2020

    Candidates for IFCC EB Regional Representative and Corporate Member position
    The IFCC Nominations Committee (NC) has completed its assessment of nominations for the election of the IFCC Regional Representatives and the Corporate Member position. The term of these positions will commence on January 1st, 2021 until December 31st 2023. All applications were declared valid. Each Regional Federation’s Full member Societies will vote for their Regional Representative. IFCC corporate members constitute the voting members for the Corporate representative
    Elections are taking place electronically from February 1st- 29th, 2020.
    Read more

  • IFCC WG GCP Survey for Genomics in Oncology

    Monday, February 10, 2020

    IFCC WG GCP Survey for Genomics in Oncology
    The ETD Working group for Guidance for the Implementation of Custom-made Genomic Panels (WG-GCP) invites you and your colleagues to complete the IFCC Genomics in Oncology Survey. The purpose of the survey is to better understand the current practices and needs of both pathologists and clinicians working in oncology. We are especially interested in responses from those institutions with limited experience who are considering moving into genomic testing in oncology. We are also seeking responses from those with genetics experience, to build a guide of best practices for those moving into this space.
    Read more

 
Website developed by Insoft